eagle-i The University of PennsylvaniaThe University of Pennsylvania
See it in Search
This page is a preview of the following resource. Continue onto eagle-i search using the button on the right to see the full record.

Oracle Adverse Event Reporting System

eagle-i ID


Resource Type

  1. Software


  1. Resource Description
    "Manufacturers of medical products such as drugs, vaccines, biologics and medical devices are required by law to report certain adverse reactions and complaints about their products in a timely fashion in all countries where the products are marketed or studied. As well as responding to these issues as they arise, manufacturers are increasingly looking to proactively identify safety issues by monitoring trends, identifying signals, and comparing products and incident rates with those of competitors. Oracle AERS gives pharmaceutical companies the power to store and monitor adverse events encountered in clinical trials so that safety concerns can be addressed before a drug reaches the market. Oracle AERS pulls adverse event information from the Oracle Clinical database to Oracle AERS, therefore preventing duplicate effort and possible database discrepancies. If the details of a clinical adverse event reach the Safety department before the data has been entered into Oracle Clinical, then the users can pick the patient and investigator information directly from the Oracle Clinical database, thus reducing possible discrepancies."
  2. Manufacturer
    Oracle Corporation
  3. Used by
    Clinical Research Computing Unit (Penn)
  4. Website(s)
  5. Related Technique
    Data acquisition
  6. Related Technique
    Clinical trial technique
  7. Software license
    Proprietary commercial software license
Provenance Metadata About This Resource Record
  1. workflow state
  2. contributor
  3. created
  4. creator
  5. modified
Copyright © 2016 by the President and Fellows of Harvard College
The eagle-i Consortium is supported by NIH Grant #5U24RR029825-02 / Copyright 2016